Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding
Study Details
Study Description
Brief Summary
The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Transvaginal sonography
|
Device: Transvaginal sonography
Transvaginal sonography will be performed to:
measure the endometrial thickness
detect the endometrial pattern
|
Outcome Measures
Primary Outcome Measures
- The accuracy of endometrial thickness and endometrial pattern detected by transvaginal ultrasound in predicting endometrial hyperplasia and endometrial cancer. [14 months]
The endometrial thickness will be measured in millimeter, at the mid-sagittal plane of the uterus, near the uterine fundus. The measurement will be performed 3 times, from basal layer of the anterior to basal layer of the posterior wall of uterine cavity. The average value of 3 measurements will be used for statistical analysis. The endometrial patterns are categorized into 3 groups: Triple-layer appearance Mixed echogenic pattern Hyper-echogenic pattern
Secondary Outcome Measures
- To identify the cut-off points of endometrial thickness that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer. [14 months]
The results of endometrial thickness will be compared with the endometrial pathologies.The cut-off points of endometrial thickness, in millimeter, that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer will be analyzed using receiver operating characteristic (ROC) curve.
Other Outcome Measures
- To study the prevalence of the various causes of abnormal uterine bleeding in premenopausal women aged more than 35 [14 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Premenopausal women aged over than 35
-
Abnormal uterine bleeding (menorrhagia/menometrorrhagia/metrorrhagia)
-
Accept transvaginal examination (pelvic examination and ultrasound)
-
Informed consent
Exclusion Criteria:
-
Severe uterine bleeding resulting in unstable vital signs
-
Pregnancy
-
Current medications: anticoagulants, selective serotonin reuptake inhibitor (SSRI), antipsychotics, corticosteroids, hormones, herbs
-
Intrauterine device
-
Genital tract pathologies: infection, submucous myoma distorting uterine cavity
-
Systemic diseases that may cause coagulopathies: Thyroid disease, liver disease, pituitary/ hypothalamus diseases
-
Not able to retrieve endometrial tissue
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University | Bangkok | Thailand | 10330 |
Sponsors and Collaborators
- Chulalongkorn University
Investigators
- Principal Investigator: Porntip Sirayapiwat, MD, MSc, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University 1873 Rama 4 Road, Patumwan, Bangkok, 10330, Thailand
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RA55/34